Plerixafor (Standard)

(Synonyms: AMD 3100 (Standard); JM3100 (Standard); SID791 (Standard))

Plerixafor (AMD 3100; JM3100; SID791) (Standard) is the analytical standard of Plerixafor (AMD 3100; JM3100; SID791) (HY-10046). This product is intended for research and analytical applications. Plerixafor (AMD 3100; JM3100; SID791) is a CXCR4 antagonist and a CXCR7 allosteric agonist; Plerixafor disrupts stem cell retention in the bone marrow by blocking the SDF-1α/CXCL12‑CXCR4 signaling pathway and inhibiting chemokine-mediated receptor internalization, mobilizing peripheral blood leukocytes, neutrophils, endothelial progenitor cells, and B cells; Plerixafor alleviates Silicon dioxide (HY-W019831)-induced pulmonary inflammation and fibrosis, inhibits corneal neovascularization and CXCL12-induced cell migration, and simultaneously suppresses ischemia-induced inflammatory responses, reduces blood-brain barrier permeability, attenuates cerebral edema, and reduces infarct volume. Plerixafor can be used in research related to liver fibrosis, silicosis, colorectal cancer, and ischemic stroke.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : 98%
  • CAS. Nr.: 110078-46-1
  • Formel: C28H54N8
  • Molecular Weight:502.78
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Reinheit & Dokumentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00